Mr. Denny joined Gilead's Board of Directors in 1996 and was appointed Lead Independent Director in May 2008. He served as Chairman from 2001 until May 2008. Previously, he was Chief Financial Officer and Vice Chair at Sears, Roebuck & Co. and held oversight responsibility for many of the company's operations and staff functions.

Mr. Denny is currently Chairman of a privately held healthcare technology company. He is a past Chairman of Northwestern Memorial Hospital and the Northwes... 

Dr. Cogan joined Gilead's Board of Directors in 2005. He is currently the Leonard and Shirley Ely Senior Fellow at the Hoover Institution and Professor of Public Policy at Stanford University, where his research focuses on U.S. budget and fiscal policy, social security and healthcare.

Dr. Cogan has held a number of positions in the U.S. government, including Assistant Secretary for Policy in the U.S. Department of Labor and Associate Director and Deputy Director in the U.S. Office... 

Mr. Davignon joined Gilead's Board of Directors in 1990. He is currently Minister of State and serves as Chairman of Recticel, CMB, SN Air Holding and Genfina and as a director of Sofina. Previously, he served as Chairman of Société Générale de Belgique, a diversified financial and industrial company.

Mr. Davignon has served as the European Community's (EC) Commissioner for Industry and International Markets and as the EC's Vice President for Research, Industry and Energy Policies. ... 

Mrs. Hills joined Gilead's Board of Directors in 2007. She is currently the Chair and Chief Executive Officer of Hills & Company, a firm providing advice to U.S. businesses on investment, trade and risk assessment issues outside the United States.

Mrs. Hills serves on the international advisory boards of J.P. Morgan Chase, Rolls Royce and the Coca-Cola Company. She is Chair of the National Committee on U.S.-China Relations and Co-Chair of the Inter-American Dialogue, the Council on Fo... 

Mr. Lofton joined Gilead’s Board of Directors in 2009. He is currently the President and Chief Executive Officer of Catholic Health Initiatives, a Denver-based healthcare system operating the full continuum of services from hospitals to home health agencies throughout the nation. He previously served as Chief Executive Officer of two university hospitals, the University of Alabama at Birmingham Hospital and Howard University Hospital in Washington, D.C. In 2007, Mr. Lofton served as Chairm... 

Mr. Madigan joined Gilead's Board of Directors in 2005. He is the retired Chairman and Chief Executive Officer of Tribune Company, a director and former chairman of the Robert R. McCormick Foundation and a director at Boise Cascade.

Mr. Madigan is also a former member of the Defense Business Board of the Department of Defense, an advisor to Madison Dearborn Partners and a director and former chairman of The Chicago Council on Global Affairs. He serves as a trustee of Northwestern Universi... 

Dr. Moore joined Gilead’s Board of Directors in 1996, after serving as a member of the company’s Business Advisory Board from 1991 until 1996. Prior to joining Gilead’s board, Dr. Moore co-founded Intel Corporation and served as Chairman, President and Chief Executive Officer.

Dr. Moore is a former Chairman and present Life Trustee of the California Institute of Technology, a member of the National Academy of Engineering and a Fellow of the Royal Society of Engineering (UK). He is ... 

Mr. Moore joined Gilead's Board of Directors in 2004. He is the retired global Chairman of PricewaterhouseCoopers, a professional services firm formed in 1998 by the merger of Coopers & Lybrand and Price Waterhouse. Prior to the merger, Mr. Moore was elected Chairman and Chief Executive Officer of Coopers & Lybrand (U.S.) in 1994 and Coopers & Lybrand International in 1997.

Mr. Moore is the lead independent director of NetApp Inc. and a director of Bechtel Group, Inc., Wells Fargo, In... 

Dr. Whitley joined Gilead's Board of Directors in 2008. He is a Distinguished Professor, Loeb Scholar Chair in Pediatrics; Director, Division of Pediatric Infectious Diseases; Vice-Chair, Department of Pediatrics; Senior Scientist, Department of Gene Therapy; Senior Scientist, Cancer Research and Training Center; Associate Director for Clinical Studies, Center for AIDS Research; and Co-Director, Center for Emerging Infections and Emergency Preparedness (CEIEP) for the institution.

Mrs. Wilson joined Gilead's Board of Directors in 2001. Mrs. Wilson served as California's First Lady from 1991-1999. She is Chair of the Ralph M. Parsons Foundation, a non-profit organization that provides grants for higher education, social impact, civic, cultural and health issues.

Mrs. Wilson is also the Chair Emeritus of the Advisory Board of the California State Summer School for Math and Science (COSMOS), a member of the Board of Trustees of the California Institute of Technolo... 

Mr. Wold-Olsen joined Gilead’s Board of Directors in 2010, after serving as the Chair of the company’s Health Policy Advisory Board since 2007. From 2005 to 2006, Mr. Wold-Olsen served as President of the Human Health Intercontinental Division of Merck & Co., Inc., a leading global pharmaceutical company. From 1997 until 2005, he served as President of Human Health Europe, Middle East/Africa and Worldwide Human Health Marketing for Merck.

Mr. Wold-Olsen is currently Chairman of t... 

Dr. Shultz served on Gilead's Board of Directors from 1996 until May 2006 and currently serves as Director Emeritus. Dr. Shultz is a Distinguished Fellow at the Hoover Institution and a director of the Fremont Group and Accretive Health.

From 1982 until 1989, Dr. Shultz served as the U.S. Secretary of State and previously served as Secretary of the Treasury, Secretary of Labor and Director of the Office of Management and Budget. He was also Dean of the Graduate School of Business ...